| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | GMF | 4.03e-05 | 2 | 119 | 2 | IPR011171 | |
| Domain | PI3/4_kinase_CS | 1.09e-04 | 15 | 119 | 3 | IPR018936 | |
| Domain | - | 1.33e-04 | 16 | 119 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 1.33e-04 | 16 | 119 | 3 | SM00146 | |
| Domain | PI3_PI4_kinase | 1.92e-04 | 18 | 119 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 1.92e-04 | 18 | 119 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.92e-04 | 18 | 119 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 1.92e-04 | 18 | 119 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 1.92e-04 | 18 | 119 | 3 | PS50290 | |
| Domain | MeTrfase | 2.40e-04 | 4 | 119 | 2 | IPR026113 | |
| Domain | EGF_Ca-bd_CS | 3.90e-04 | 97 | 119 | 5 | IPR018097 | |
| Domain | EGF_CA | 4.28e-04 | 99 | 119 | 5 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.49e-04 | 100 | 119 | 5 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.86e-04 | 106 | 119 | 5 | IPR000152 | |
| Domain | Methyltransf_12 | 5.94e-04 | 6 | 119 | 2 | IPR013217 | |
| Domain | Methyltransf_12 | 5.94e-04 | 6 | 119 | 2 | PF08242 | |
| Pubmed | 1.60e-07 | 4 | 120 | 3 | 26998831 | ||
| Pubmed | 3.97e-07 | 18 | 120 | 4 | 25761772 | ||
| Pubmed | SoxC transcription factors are essential for the development of the inner ear. | 3.99e-07 | 5 | 120 | 3 | 26504244 | |
| Pubmed | 7.95e-07 | 6 | 120 | 3 | 18403418 | ||
| Pubmed | 7.95e-07 | 6 | 120 | 3 | 18505825 | ||
| Pubmed | 9.40e-07 | 22 | 120 | 4 | 24310815 | ||
| Pubmed | Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets. | 1.30e-06 | 157 | 120 | 7 | 30686591 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SOX4 PER1 GEMIN5 FRYL MLLT10 BAHD1 ST14 ADCY9 FAT1 IGF2R PIK3C2B PI4KA HELZ2 PXN HERC1 ZC3H7B | 1.36e-06 | 1105 | 120 | 16 | 35748872 |
| Pubmed | 2.22e-06 | 8 | 120 | 3 | 25261715 | ||
| Pubmed | SOX11 and SOX4 drive the reactivation of an embryonic gene program during murine wound repair. | 3.31e-06 | 9 | 120 | 3 | 31492871 | |
| Pubmed | 4.72e-06 | 10 | 120 | 3 | 28215559 | ||
| Pubmed | ALDH1B1 is a potential stem/progenitor marker for multiple pancreas progenitor pools. | 6.48e-06 | 11 | 120 | 3 | 23142317 | |
| Pubmed | 8.61e-06 | 12 | 120 | 3 | 11071752 | ||
| Pubmed | 8.61e-06 | 12 | 120 | 3 | 7590241 | ||
| Pubmed | Seven new members of the Sox gene family expressed during mouse development. | 1.12e-05 | 13 | 120 | 3 | 8441686 | |
| Pubmed | Cis-regulatory control of corticospinal system development and evolution. | 1.12e-05 | 13 | 120 | 3 | 22678282 | |
| Pubmed | SOXC proteins amplify canonical WNT signaling to secure nonchondrocytic fates in skeletogenesis. | 1.12e-05 | 13 | 120 | 3 | 25452386 | |
| Pubmed | 1.12e-05 | 13 | 120 | 3 | 28411269 | ||
| Pubmed | 1.12e-05 | 13 | 120 | 3 | 23559562 | ||
| Pubmed | Differential expression of SOX4 and SOX11 in medulloblastoma. | 1.18e-05 | 2 | 120 | 2 | 12125983 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 27188524 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 22378879 | ||
| Pubmed | Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα. | 1.18e-05 | 2 | 120 | 2 | 23752693 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 27223053 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 20517925 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 26315408 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 23532846 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 36068255 | ||
| Pubmed | Isolation of novel human cDNA (hGMF-gamma) homologous to Glia Maturation Factor-beta gene. | 1.18e-05 | 2 | 120 | 2 | 9545571 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 31413360 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 25703587 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 8663198 | ||
| Pubmed | A sex-specific evolutionary interaction between ADCY9 and CETP. | 1.18e-05 | 2 | 120 | 2 | 34609279 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 24874076 | ||
| Pubmed | Adcy9 Gene Inactivation Improves Cardiac Function After Myocardial Infarction in Mice. | 1.18e-05 | 2 | 120 | 2 | 37054880 | |
| Pubmed | IRE1α regulates macrophage polarization, PD-L1 expression, and tumor survival. | 1.18e-05 | 2 | 120 | 2 | 32520957 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 26755628 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 34026438 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 11435704 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 23318640 | ||
| Pubmed | 1.42e-05 | 14 | 120 | 3 | 8921394 | ||
| Pubmed | 1.42e-05 | 14 | 120 | 3 | 18258609 | ||
| Pubmed | 1.77e-05 | 15 | 120 | 3 | 15654505 | ||
| Pubmed | 1.77e-05 | 15 | 120 | 3 | 18990750 | ||
| Pubmed | Differential isoform expression and alternative splicing in sex determination in mice. | 1.77e-05 | 15 | 120 | 3 | 30871468 | |
| Pubmed | 1.77e-05 | 15 | 120 | 3 | 26826126 | ||
| Pubmed | Spatio-temporal expression of Sox genes in murine palatogenesis. | 2.63e-05 | 17 | 120 | 3 | 27241892 | |
| Pubmed | SOX4 cooperates with neurogenin 3 to regulate endocrine pancreas formation in mouse models. | 3.15e-05 | 18 | 120 | 3 | 25652387 | |
| Pubmed | 3.15e-05 | 18 | 120 | 3 | 26864488 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 25804118 | ||
| Pubmed | Phorbol ester stimulates rapid intracellular phosphorylation of glia maturation factor. | 3.53e-05 | 3 | 120 | 2 | 7598724 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 32418990 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 20646169 | ||
| Pubmed | Berberine-induced activation of AMPK increases hepatic FGF21 expression via NUR77. | 3.53e-05 | 3 | 120 | 2 | 29247651 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 25170079 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 29749639 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 8798479 | ||
| Pubmed | Expression of Sox4 and Sox11 is regulated by multiple mechanisms during retinal development. | 3.53e-05 | 3 | 120 | 2 | 23313252 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 21527504 | ||
| Pubmed | Repression and 3D-restructuring resolves regulatory conflicts in evolutionarily rearranged genomes. | 3.53e-05 | 3 | 120 | 2 | 36179666 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 32427860 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 29217200 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 16447040 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 19125366 | ||
| Pubmed | 3.73e-05 | 19 | 120 | 3 | 20596238 | ||
| Pubmed | 4.37e-05 | 20 | 120 | 3 | 12447396 | ||
| Pubmed | Transcriptome profiling of mouse brain and lung under Dip2a regulation using RNA-sequencing. | 4.37e-05 | 20 | 120 | 3 | 31291246 | |
| Pubmed | 4.37e-05 | 20 | 120 | 3 | 19751749 | ||
| Pubmed | The HMG box transcription factor Sox4 contributes to the development of the endocrine pancreas. | 5.09e-05 | 21 | 120 | 3 | 16306355 | |
| Pubmed | Expression of Sox transcription factors in the developing mouse pancreas. | 5.09e-05 | 21 | 120 | 3 | 12815626 | |
| Pubmed | Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. | 5.54e-05 | 117 | 120 | 5 | 18996102 | |
| Pubmed | 6.44e-05 | 62 | 120 | 4 | 20403997 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 23484127 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 27966786 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 11738826 | ||
| Pubmed | Vinculin regulates cell-surface E-cadherin expression by binding to beta-catenin. | 7.05e-05 | 4 | 120 | 2 | 20086044 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 8639570 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 20007910 | ||
| Pubmed | Mutually exclusive substrate selection strategy by human m3C RNA transferases METTL2A and METTL6. | 7.05e-05 | 4 | 120 | 2 | 34268557 | |
| Pubmed | Sox4 links tumor suppression to accelerated aging in mice by modulating stem cell activation. | 7.69e-05 | 24 | 120 | 3 | 25043184 | |
| Pubmed | A cluster of three long-range enhancers directs regional Shh expression in the epithelial linings. | 8.72e-05 | 25 | 120 | 3 | 19369396 | |
| Pubmed | 8.72e-05 | 25 | 120 | 3 | 16006997 | ||
| Pubmed | 9.13e-05 | 130 | 120 | 5 | 12421765 | ||
| Pubmed | 9.56e-05 | 529 | 120 | 9 | 14621295 | ||
| Pubmed | Cooperative function of POU proteins and SOX proteins in glial cells. | 1.17e-04 | 5 | 120 | 2 | 9632656 | |
| Pubmed | Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. | 1.17e-04 | 5 | 120 | 2 | 16598069 | |
| Pubmed | Three distinct 3-methylcytidine (m3C) methyltransferases modify tRNA and mRNA in mice and humans. | 1.17e-04 | 5 | 120 | 2 | 28655767 | |
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 32958856 | ||
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 17035385 | ||
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 21521737 | ||
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 24021877 | ||
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 21266507 | ||
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 15111333 | ||
| Pubmed | 1.17e-04 | 5 | 120 | 2 | 24670948 | ||
| Pubmed | Sohlh2 affects differentiation of KIT positive oocytes and spermatogonia. | 1.23e-04 | 28 | 120 | 3 | 19014927 | |
| Pubmed | 1.52e-04 | 30 | 120 | 3 | 35830813 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.65e-04 | 569 | 120 | 9 | 30639242 | |
| Pubmed | 1.74e-04 | 80 | 120 | 4 | 19420105 | ||
| Pubmed | 1.75e-04 | 6 | 120 | 2 | 17548691 | ||
| Pubmed | 1.75e-04 | 6 | 120 | 2 | 30385877 | ||
| GeneFamily | SRY-boxes | 7.97e-05 | 19 | 81 | 3 | 757 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.50e-07 | 178 | 120 | 7 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | CF-Lymphoid-pDC|Lymphoid / Disease state, Lineage and Cell class | 7.67e-07 | 187 | 120 | 7 | adc79e5804ab98006dbdf1d76ef0d8f85cc5cb0f | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-07 | 189 | 120 | 7 | 319e42f6e2322208de78bc666fb2c074707eb4da | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.12e-06 | 198 | 120 | 7 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 199 | 120 | 7 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-06 | 199 | 120 | 7 | c972d3036151403f26fa9d6271520639c281ab84 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease, condition lineage and cell class | 1.20e-06 | 200 | 120 | 7 | ac9d7927863348a752444d2e80269a5eead943b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-06 | 156 | 120 | 6 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-06 | 156 | 120 | 6 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | NS-critical-d_0-4-Myeloid-Monocyte-derived_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.81e-06 | 170 | 120 | 6 | adf73bdc049d508f8873c22539db2ca92052a97b | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.58e-06 | 177 | 120 | 6 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.86e-06 | 178 | 120 | 6 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | mild-Myeloid-pDC|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.44e-06 | 180 | 120 | 6 | 38614155fa537d0defda914c531c697be0ef06d8 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 182 | 120 | 6 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | (7)_DC_plasmacytoid|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.04e-05 | 183 | 120 | 6 | 2c6475c935b5a90931be6b3c53f1f707cfcd11f4 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 183 | 120 | 6 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-05 | 184 | 120 | 6 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class | 1.07e-05 | 184 | 120 | 6 | ad6e910eaebe841a68a5f2f329d43dafc5db158a | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.07e-05 | 184 | 120 | 6 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.07e-05 | 184 | 120 | 6 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.07e-05 | 184 | 120 | 6 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-05 | 185 | 120 | 6 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 186 | 120 | 6 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 1.17e-05 | 187 | 120 | 6 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 188 | 120 | 6 | 8385fd384fc55e3b17802bb6698eb93b2c16d7f2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.21e-05 | 188 | 120 | 6 | b04fd6a724c117eb9a979c29b91f90113feb7a5c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 188 | 120 | 6 | cb9d0b48e2fd9cc576132803273b9c0382900944 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-05 | 189 | 120 | 6 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 190 | 120 | 6 | 050d6e0546954675b6adbfecb67854b1e09739d1 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Activated_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.28e-05 | 190 | 120 | 6 | 15978ddd37b521343f88b62dad1643077fc22b2b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 196 | 120 | 6 | 023477a499a2c190f363cfdbc9d9c646733a6541 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 196 | 120 | 6 | 3cb74f1a333a82cac2b459f2f1517e2acf22b5fd | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.53e-05 | 196 | 120 | 6 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-05 | 196 | 120 | 6 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.62e-05 | 198 | 120 | 6 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.62e-05 | 198 | 120 | 6 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 1.67e-05 | 199 | 120 | 6 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Serous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.72e-05 | 200 | 120 | 6 | 7c2d499af60654b7b28f172ac2c914ad49fb74b4 | |
| ToppCell | 10x_3'_v2v3-Neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.72e-05 | 200 | 120 | 6 | e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Macroglial-Astrocyte|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.72e-05 | 200 | 120 | 6 | 4fe3b2d80c567c18621bff3341f9a73578c81621 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Macroglial-Astrocyte|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.72e-05 | 200 | 120 | 6 | 7c66953ff6d8f16f4decd23c85232990d2d8c6c4 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-05 | 123 | 120 | 5 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.47e-05 | 165 | 120 | 5 | 1c3709ac9f96ace1f3b28e1f2f15b4a8d65885ca | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.47e-05 | 165 | 120 | 5 | fbc7d97e6f30975d35c76a7c97947a34cf5975d2 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 8.96e-05 | 167 | 120 | 5 | 7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.22e-05 | 168 | 120 | 5 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.00e-04 | 171 | 120 | 5 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 172 | 120 | 5 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 175 | 120 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 92 | 120 | 4 | bbaf5a131f860198840e34843b7c841bcc98d9c4 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.12e-04 | 92 | 120 | 4 | e6aa2b8ca9235a7291ee41d976b886fec185835d | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.18e-04 | 177 | 120 | 5 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 181 | 120 | 5 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 181 | 120 | 5 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 182 | 120 | 5 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-04 | 182 | 120 | 5 | 9bbe8062aa562dc3b9c299581faf6ebbcb72a9f7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-04 | 182 | 120 | 5 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-plasmacytoid_dendritic_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.34e-04 | 182 | 120 | 5 | 4602a98df7045e2c70b7560abfba9b444fbd5d30 | |
| ToppCell | severe-Myeloid-Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.38e-04 | 183 | 120 | 5 | 60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 183 | 120 | 5 | 2df1611c8acccb2a6f233d3d68bd9df2381a7278 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 183 | 120 | 5 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 183 | 120 | 5 | 98fee6838acfaee5e2e449ba088764ec06b8bc57 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 184 | 120 | 5 | 6388c47b7f1d8203e3069eba0e74107256dcae51 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 184 | 120 | 5 | 235890e8b424f4386b6ea52d173d20a00898df73 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 184 | 120 | 5 | 5939527d24d299e562e707469c9123890edd76be | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-04 | 184 | 120 | 5 | a2191dd5546efd357b23e625beb3c5820476f243 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 184 | 120 | 5 | d83ae1dc64aa1b27d3b524c137567418cc0ff8c6 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 120 | 5 | 3d1353dbcb60e2531ef67e1bd218b7bc4d7c7c9b | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 120 | 5 | 995a8ddc3fd8e6879d8b5de8cbdefe232d34833b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 185 | 120 | 5 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 185 | 120 | 5 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 185 | 120 | 5 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 185 | 120 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 185 | 120 | 5 | 19fa853f6f746ccf232a343b3c9c7a5e55800409 | |
| ToppCell | Healthy_donor-pDC|Healthy_donor / disease group, cell group and cell class (v2) | 1.45e-04 | 185 | 120 | 5 | 7fbb55cbdb39bdecb6063c8ba9776ab06c2666e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-04 | 185 | 120 | 5 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 186 | 120 | 5 | d57c40b3fe5cfc87e771df76533d9a3e94678b04 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 186 | 120 | 5 | 90eaf6ffb4ce0c34fa1e79f0c8f36f217f44973b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-04 | 186 | 120 | 5 | bd8a9753df219084e19e7f94447856e86608325c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.52e-04 | 187 | 120 | 5 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 187 | 120 | 5 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 187 | 120 | 5 | 97e520705491c8f52a32025311a9fa7b9176979a | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 120 | 5 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-04 | 187 | 120 | 5 | b71d0cd91bc98e020757c1d071a13ad48d718bcf | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 120 | 5 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 120 | 5 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | control-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.52e-04 | 187 | 120 | 5 | c78aee98b32719aa45811b620fc97be1ecf5fd53 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-04 | 188 | 120 | 5 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.56e-04 | 188 | 120 | 5 | 60242c29c7f16c94a84685d3bc4ed93a66e70152 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 188 | 120 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.56e-04 | 188 | 120 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 188 | 120 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.60e-04 | 189 | 120 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 189 | 120 | 5 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-pDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.60e-04 | 189 | 120 | 5 | 6c2ace61a7d62bcf7e76b73e2da8b722d03e713b | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 189 | 120 | 5 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 189 | 120 | 5 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 1.60e-04 | 189 | 120 | 5 | aac79c41ce7acba722c45c016b2c6997fb772a96 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 189 | 120 | 5 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease group, lineage and cell class | 1.60e-04 | 189 | 120 | 5 | c6cfd6aa21c19f2c62d80218bbc924e14e82aada | |
| Drug | celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA | 6.43e-06 | 187 | 119 | 8 | 887_DN | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; PC3; HT_HG-U133A | 8.73e-06 | 195 | 119 | 8 | 6339_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 9.41e-06 | 197 | 119 | 8 | 1697_DN | |
| Drug | Biotin [58-85-5]; Up 200; 16.4uM; HL60; HT_HG-U133A | 9.41e-06 | 197 | 119 | 8 | 2428_UP | |
| Disease | Malignant neoplasm of salivary gland | 1.01e-06 | 45 | 118 | 5 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 1.26e-06 | 47 | 118 | 5 | C0036095 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 5.79e-06 | 111 | 118 | 6 | EFO_0004530, EFO_0008595 | |
| Disease | lung adenocarcinoma (implicated_via_orthology) | 4.74e-05 | 3 | 118 | 2 | DOID:3910 (implicated_via_orthology) | |
| Disease | 1-palmityl-2-palmitoyl-GPC (O-16:0/16:0) measurement | 4.74e-05 | 3 | 118 | 2 | EFO_0800515 | |
| Disease | level of Phosphatidylcholine (O-16:1_18:2) in blood serum | 4.74e-05 | 3 | 118 | 2 | OBA_2045121 | |
| Disease | Adenoid Cystic Carcinoma | 5.22e-05 | 100 | 118 | 5 | C0010606 | |
| Disease | phospholipids in medium VLDL measurement | 5.67e-05 | 52 | 118 | 4 | EFO_0022154 | |
| Disease | cholesterol in small VLDL measurement | 6.12e-05 | 53 | 118 | 4 | EFO_0022228 | |
| Disease | triglycerides in IDL measurement | 8.73e-05 | 58 | 118 | 4 | EFO_0022149 | |
| Disease | gout | 1.41e-04 | 196 | 118 | 6 | EFO_0004274 | |
| Disease | total lipids in small VLDL | 1.53e-04 | 67 | 118 | 4 | EFO_0022148 | |
| Disease | matrix-remodeling-associated protein 8 measurement | 1.57e-04 | 5 | 118 | 2 | EFO_0802731 | |
| Disease | level of Phosphatidylcholine (O-16:0_16:1) in blood serum | 1.57e-04 | 5 | 118 | 2 | OBA_2045112 | |
| Disease | level of Phosphatidylcholine (O-16:0_18:1) in blood serum | 1.57e-04 | 5 | 118 | 2 | OBA_2045113 | |
| Disease | level of Phosphatidylcholine (O-18:1_16:0) in blood serum | 1.57e-04 | 5 | 118 | 2 | OBA_2045128 | |
| Disease | obesity (implicated_via_orthology) | 2.33e-04 | 215 | 118 | 6 | DOID:9970 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.64e-04 | 220 | 118 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 2.76e-04 | 78 | 118 | 4 | EFO_0022187 | |
| Disease | Liver Cirrhosis, Experimental | 2.83e-04 | 774 | 118 | 11 | C0023893 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.91e-04 | 224 | 118 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.27e-04 | 229 | 118 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | Helicobacter Infections | 3.29e-04 | 7 | 118 | 2 | C0079487 | |
| Disease | histone-lysine n-methyltransferase EHMT2 measurement | 3.29e-04 | 7 | 118 | 2 | EFO_0020455 | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.41e-04 | 34 | 118 | 3 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | level of Phosphatidylcholine (18:1_18:1) in blood serum | 4.37e-04 | 8 | 118 | 2 | OBA_2045099 | |
| Disease | Ventricular Dysfunction | 4.37e-04 | 8 | 118 | 2 | C0242973 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 4.39e-04 | 37 | 118 | 3 | EFO_0022252 | |
| Disease | cholesterol in very small VLDL measurement | 5.53e-04 | 40 | 118 | 3 | EFO_0022231 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 6.39e-04 | 42 | 118 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 6.99e-04 | 10 | 118 | 2 | EFO_0800464 | |
| Disease | level of phosphatidylcholine | 6.99e-04 | 10 | 118 | 2 | OBA_2040179 | |
| Disease | cholesterol in medium VLDL measurement | 7.33e-04 | 44 | 118 | 3 | EFO_0022225 | |
| Disease | total lipids in very small VLDL measurement | 7.83e-04 | 45 | 118 | 3 | EFO_0022156 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 8.35e-04 | 46 | 118 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 8.39e-04 | 274 | 118 | 6 | EFO_0004530, EFO_0004612 | |
| Disease | free cholesterol in small VLDL measurement | 8.89e-04 | 47 | 118 | 3 | EFO_0022272 | |
| Disease | free cholesterol in very small VLDL measurement | 8.89e-04 | 47 | 118 | 3 | EFO_0022275 | |
| Disease | free cholesterol in medium VLDL measurement | 8.89e-04 | 47 | 118 | 3 | EFO_0022269 | |
| Disease | remnant cholesterol measurement | 9.45e-04 | 108 | 118 | 4 | EFO_0010815 | |
| Disease | phosphoglycerides measurement | 9.46e-04 | 48 | 118 | 3 | EFO_0022291 | |
| Disease | liver disease (is_implicated_in) | 1.02e-03 | 12 | 118 | 2 | DOID:409 (is_implicated_in) | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 1.02e-03 | 12 | 118 | 2 | EFO_0800466 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 1.07e-03 | 50 | 118 | 3 | EFO_0022303 | |
| Disease | free cholesterol measurement | 1.12e-03 | 113 | 118 | 4 | EFO_0008591 | |
| Disease | phospholipids in very small VLDL measurement | 1.13e-03 | 51 | 118 | 3 | EFO_0022300 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 1.20e-03 | 197 | 118 | 5 | EFO_0005680 | |
| Disease | Coffin-Siris syndrome | 1.20e-03 | 13 | 118 | 2 | C0265338 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 1.20e-03 | 13 | 118 | 2 | OBA_2045072 | |
| Disease | daytime rest measurement | 1.23e-03 | 295 | 118 | 6 | EFO_0007828 | |
| Disease | triglycerides in HDL measurement | 1.26e-03 | 53 | 118 | 3 | EFO_0022317 | |
| Disease | metabolic syndrome | 1.28e-03 | 200 | 118 | 5 | EFO_0000195 | |
| Disease | cholesterol efflux capacity measurement | 1.40e-03 | 14 | 118 | 2 | EFO_0009132 | |
| Disease | level of Phosphatidylcholine (18:1_18:2) in blood serum | 1.40e-03 | 14 | 118 | 2 | OBA_2045100 | |
| Disease | triglycerides in very large HDL measurement | 1.41e-03 | 55 | 118 | 3 | EFO_0022324 | |
| Disease | phospholipids in medium HDL measurement | 1.41e-03 | 55 | 118 | 3 | EFO_0022295 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 1.41e-03 | 55 | 118 | 3 | EFO_0022288 | |
| Disease | 1,3,7-trimethylurate measurement | 1.61e-03 | 15 | 118 | 2 | EFO_0021172 | |
| Disease | lysophosphatidylethanolamine 18:0 measurement | 1.61e-03 | 15 | 118 | 2 | EFO_0010367 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 1.61e-03 | 15 | 118 | 2 | EFO_0022328 | |
| Disease | level of Phosphatidylcholine (O-18:1_20:4) in blood serum | 1.61e-03 | 15 | 118 | 2 | OBA_2045131 | |
| Disease | level of Phosphatidylcholine (16:0_16:0) in blood serum | 1.61e-03 | 15 | 118 | 2 | OBA_2045067 | |
| Disease | low density lipoprotein particle size measurement | 1.64e-03 | 58 | 118 | 3 | EFO_0008593 | |
| Disease | total lipids in medium HDL measurement | 1.64e-03 | 58 | 118 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 1.64e-03 | 58 | 118 | 3 | EFO_0022267 | |
| Disease | docosahexaenoic acid measurement | 1.72e-03 | 127 | 118 | 4 | EFO_0007761 | |
| Disease | cholesterol in medium HDL measurement | 1.72e-03 | 59 | 118 | 3 | EFO_0021903 | |
| Disease | phospholipids in VLDL measurement | 1.72e-03 | 59 | 118 | 3 | EFO_0022301 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.76e-03 | 215 | 118 | 5 | EFO_0008317, EFO_0008591 | |
| Disease | phospholipids in small VLDL measurement | 1.81e-03 | 60 | 118 | 3 | EFO_0022146 | |
| Disease | total lipids in VLDL measurement | 1.81e-03 | 60 | 118 | 3 | EFO_0022314 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 1.81e-03 | 60 | 118 | 3 | EFO_0022282 | |
| Disease | level of Phosphatidylcholine (18:0_18:2) in blood serum | 1.83e-03 | 16 | 118 | 2 | OBA_2045090 | |
| Disease | fatty acid measurement | 1.89e-03 | 436 | 118 | 7 | EFO_0005110 | |
| Disease | free cholesterol in VLDL measurement | 1.89e-03 | 61 | 118 | 3 | EFO_0022276 | |
| Disease | free cholesterol in HDL measurement | 1.89e-03 | 61 | 118 | 3 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 1.89e-03 | 61 | 118 | 3 | EFO_0022293 | |
| Disease | fatty liver disease (is_marker_for) | 2.07e-03 | 17 | 118 | 2 | DOID:9452 (is_marker_for) | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 2.07e-03 | 17 | 118 | 2 | EFO_0022232 | |
| Disease | total lipids in HDL measurement | 2.08e-03 | 63 | 118 | 3 | EFO_0022307 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 2.11e-03 | 224 | 118 | 5 | EFO_0004574, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 2.33e-03 | 18 | 118 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 2.33e-03 | 18 | 118 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (15:0_18:2) in blood serum | 2.33e-03 | 18 | 118 | 2 | OBA_2045065 | |
| Disease | triglycerides in very small VLDL measurement | 2.59e-03 | 68 | 118 | 3 | EFO_0022144 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 2.59e-03 | 19 | 118 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.59e-03 | 19 | 118 | 2 | C1333991 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 2.59e-03 | 19 | 118 | 2 | EFO_0802076 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.59e-03 | 19 | 118 | 2 | C2936783 | |
| Disease | level of Phosphatidylcholine (16:0_18:2) in blood serum | 2.87e-03 | 20 | 118 | 2 | OBA_2045071 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 2.99e-03 | 243 | 118 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | phospholipids in large HDL measurement | 3.16e-03 | 73 | 118 | 3 | EFO_0022190 | |
| Disease | saturated fatty acids to total fatty acids percentage | 3.17e-03 | 21 | 118 | 2 | EFO_0022305 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.17e-03 | 21 | 118 | 2 | EFO_0022277 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 3.17e-03 | 21 | 118 | 2 | EFO_0022246 | |
| Disease | level of Phosphatidylcholine (16:1_18:2) in blood serum | 3.17e-03 | 21 | 118 | 2 | OBA_2045083 | |
| Disease | total lipids in large HDL | 3.29e-03 | 74 | 118 | 3 | EFO_0022189 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.37e-03 | 153 | 118 | 4 | EFO_0004611, EFO_0020946 | |
| Disease | Prostatic Neoplasms | 3.39e-03 | 616 | 118 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.39e-03 | 616 | 118 | 8 | C0376358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GRVRTDAPDCYLSFH | 151 | P11597 | |
| TIPVDGDYFTFTRHE | 161 | O94788 | |
| GDYFTFTRHEPIGVC | 166 | O94788 | |
| LSFYLGCDKFPHESE | 871 | Q8IUX7 | |
| TYFHRKSQEDFCGPE | 711 | Q9NZJ0 | |
| GNTYFVFVPLEEEHC | 826 | Q9P1Z9 | |
| GTIECEGPNRHLYDF | 236 | Q9NTI2 | |
| PEDFCFYQGSLRSHR | 141 | Q8TE57 | |
| HLARDFGYVCETEFP | 306 | Q6VUC0 | |
| SDPGNYHEFCRFLAR | 321 | Q9H2T7 | |
| IFYCTFRRLDPEENH | 206 | Q9NZQ7 | |
| LPVEDAYFHSCVFDV | 351 | Q6ZVN8 | |
| ACNEFYTRIPHDFGL | 301 | Q9UGN5 | |
| DPECFAHLLRFYDGI | 411 | O00255 | |
| CYHGVIEEDLTPFRG | 56 | Q8NBL1 | |
| YAHIEESVDVSPGCF | 3996 | Q14517 | |
| EISHPDVGRYFSEFT | 576 | O94952 | |
| EETFPHICAALGDYV | 626 | Q6W4X9 | |
| IEVPCSEDYDSHRRF | 86 | Q6PK18 | |
| SEDYDSHRRFEGCTP | 91 | Q6PK18 | |
| FGLDVVEVDPTTHCY | 166 | A2A368 | |
| VHDDGRVSYPLCFIF | 76 | O60234 | |
| AVYAFHLCEDGAEPT | 356 | Q86UE6 | |
| YTDTCDFLTHGFKPR | 636 | Q9P2D0 | |
| CVEYHAFFRLSEEPK | 271 | Q6ZUT3 | |
| HRPYCVDLEESTFSH | 746 | Q15751 | |
| CAALTTDHIERYGFP | 1006 | Q8IY21 | |
| DHSPIRFCARNGEYV | 421 | O15534 | |
| LPILDADEYFHCAFG | 551 | Q9ULL4 | |
| FYGSDELHQFFCDVP | 166 | Q8NGZ2 | |
| YCGAHEIDHFFCETP | 166 | A6NH00 | |
| ERFLYACGFASHPNE | 391 | P55157 | |
| LVYCPELHFSEFTSA | 411 | Q8NDH3 | |
| FSFVVCYKHGPLADD | 251 | A6NFY4 | |
| RDFAYDSEVPSCHSI | 261 | P50549 | |
| YGSLHFDPEACSFRE | 111 | Q9NSA1 | |
| AIFIGFDHCHPEVYE | 1626 | O94915 | |
| SEYDPSRCFAFVHDL | 226 | Q6P1Q9 | |
| FHYFEASCLPDGTAL | 281 | P42356 | |
| RIPENFFEEESRYHC | 1046 | O60449 | |
| PRLHEVECSVFYRDE | 76 | Q96KN1 | |
| YCGAHEIDHFFCETP | 166 | Q8NG76 | |
| SHFRDAYPTCEVVDV | 246 | O94886 | |
| SEYDPSRCFAFVHDL | 226 | Q96IZ6 | |
| PPEVAECDLVYTFFH | 1461 | O00750 | |
| SPCSRVGEEEHVYSF | 106 | P49023 | |
| YVCFDQFPSDSHRLS | 196 | P25929 | |
| RFTPPLEDSCFHYGF | 71 | P07099 | |
| PDDFVCYFTSRFPHL | 926 | O75460 | |
| YHSTPDRLFCVDIDE | 1186 | P35555 | |
| FCHYVVSRDPTAFSE | 426 | Q02318 | |
| TDPELVFLCRHVYDF | 756 | Q8TBE0 | |
| FETFGYHFRDEACFP | 256 | O60503 | |
| GSRFFCEPVLTEEYH | 1071 | Q96PY5 | |
| FDVETHPETLCPYDF | 231 | O00187 | |
| RLLECLEFDPEEFYH | 281 | O60307 | |
| IDPDLGYSFLHVRDC | 171 | Q9NPG1 | |
| VDYSFFTEPVSCEVH | 276 | Q96J84 | |
| GCRYSHDDPEFRELL | 211 | Q16678 | |
| PERYRHCSFVPETFE | 1126 | Q9BYK8 | |
| VDYEEFVRGCHLGVF | 491 | P13807 | |
| FGTPVYCHVRETERD | 666 | Q56UN5 | |
| EPCHPGFDAESYTFT | 26 | P12830 | |
| PLSGRYFANCHVEEV | 276 | Q6UX07 | |
| VRALGSEPHFFDRCY | 116 | Q96QI5 | |
| SEPHFFDRCYERGLA | 121 | Q96QI5 | |
| SEHPEYRVFLFSCFL | 36 | Q8NGR1 | |
| GIPRDEHCFYEVEVA | 131 | Q9BZA8 | |
| VTFCGPREIHYLFCD | 166 | P47884 | |
| VTFCGPREIHYLFCD | 166 | P58170 | |
| QHDDGRVSYPLCFIF | 76 | P60983 | |
| IPEFSHETADCQYLF | 2256 | P11717 | |
| SLGSHFEFPDYCTPE | 406 | P35716 | |
| GSHFEFPDYCTPEVS | 441 | Q06945 | |
| VEHDCFALYPGPATF | 31 | P07204 | |
| NIRFEAFEKGHCYEP | 556 | Q9BYH1 | |
| TCVDVYERDLEPHSF | 91 | Q9Y3Q8 | |
| DVHSFIRSLPGCSDY | 331 | Q7Z3H4 | |
| CYPHIFSTNFRDTVD | 306 | Q96Q15 | |
| ISFIEDPERKYHFEC | 76 | Q9NW61 | |
| YMCSRFFIDFPHIEE | 261 | Q8NEK8 | |
| IDLELPCFHVGYFRA | 86 | O14802 | |
| LGRLEHAFCTETRPY | 191 | Q9BV20 | |
| FAHACTLSDYVRPEF | 626 | O15457 | |
| FEDQRPYCFSIVAGH | 381 | Q9NY99 | |
| RIECIFFSEFHPTLG | 6 | Q8WTW4 | |
| YVEEEDFHPPLSSCS | 81 | Q9NUC0 | |
| PESFFGYHCETVSDP | 856 | Q8TER0 | |
| YALLCGTLPFDDDHV | 216 | Q13131 | |
| YRHDGACPTTTFSEL | 546 | P55197 | |
| DFFSYTRHEPVGVCG | 166 | P05091 | |
| FTECGEKGEYIHFTP | 121 | Q14CN2 | |
| TVCFYGHLDVQPADR | 126 | Q96KN2 | |
| PHVYEFASDIAPFLC | 651 | Q99570 | |
| QFCDFRYSKSHGPDV | 526 | Q9UHF7 | |
| TNDCFVYHFLLEERP | 41 | Q8WUH2 | |
| HSRFPAERDISVYCG | 31 | Q8TCW7 | |
| CGKAFDYPSRFRTHE | 201 | P52737 | |
| PAVFSADYRGCHVLE | 91 | P60852 | |
| YRAIREHGFYVTDCP | 196 | H3BPM6 | |
| HVECARFSPDGQYLV | 216 | Q2TAY7 | |
| GTSHFEFPDYCTPEV | 281 | O15370 | |
| GSHLDIPAEREYDFC | 386 | Q9P2F5 | |
| RVYSFPCIAAFADEH | 291 | Q5T4T6 | |
| HCYIDDRGFRYSDPT | 656 | Q9Y5Y6 | |
| VYSAFLPDGCDHLRD | 1246 | Q8TEQ6 | |
| YDVCPHVSDSGLFFD | 241 | Q9C0C9 | |
| HFGTRYVCQFPDQEE | 86 | P40238 | |
| DYLRDPVTIDCGHVF | 21 | Q12899 | |
| FLVHTGEKPFRCTFE | 236 | Q96MM3 | |
| YVGNCSFAHSPEERE | 786 | Q8IWR0 | |
| FCYEDVTGPHEAFSK | 51 | Q63HK3 | |
| ECGRAFIYPSTFQRH | 256 | Q68EA5 | |
| LTHTFRDPGDYCFSI | 301 | Q8N3G9 | |
| HLGYFPTDLFACSES | 166 | Q9NX45 | |
| EGPYECAECEISFRH | 571 | Q9ULD5 | |
| EFCRYGAAEPHTIAA | 481 | Q13564 | |
| SLYICDPFSGVVFDH | 56 | Q92547 | |
| CEVERFTATSFGHPY | 301 | P01266 | |
| VVFARGIFCHYLEEG | 166 | Q9HAW7 | |
| PHRSSCFELYGFDVL | 341 | Q6EMB2 | |
| YVGNCSFAHSPEERD | 771 | Q9UGR2 | |
| DGASRIFFEPSLYHC | 391 | Q9UPR5 |